Patents Assigned to RB Health (US) LLC
-
Patent number: 11896698Abstract: A personal wash composition which provides an effective antimicrobial benefit against fungi, gram positive and gram negative bacteria, which composition comprises: a) from 0.1% to 10 wt % betaine surfactant, b) from 0.1% to 5.0 wt % lactic acid, c) from 0.1% to 20 wt % polyhydric C2-C6 alcohol, d) from 0% to 10 wt % alkyl polyethoxy carboxylate of the formula RO(CH2CH2O)kCH2COO?M+ wherein R is a C8-C22 alkyl, k is an integer from 0 to 20, and M is a soluble salt-forming cation, e) from 0% to 10 wt % alkyl polyethoxy amides of the formula RO(CH2CH2O)kCH2CONH2 wherein R is a C8-C22 alkyl, k is an integer from 0 to 20, f) >8 wt % alkyl ether sulphate, g) water, h) a pH of 3.8-4.5, i) 10-20 wt % total surfactant, j) from 0.1 to 10 wt % metal salt.Type: GrantFiled: September 30, 2016Date of Patent: February 13, 2024Assignee: RB Health (US) LLCInventors: Jessica Wilson, Sarah Frances de Szalay, Elizabeth Bruning, Rui Yang
-
Patent number: 11576880Abstract: Disclosed are acidic feminine intimate cleansing compositions having a pH in the range of from 3 to 5, which further necessarily comprises at least: as a primary antimicrobial active constituent, lactic acid, which may optionally be a substituted lactic acid and/or derivative thereof; and which composition further includes an anionic constituent system which boosts the antimicrobial efficacy of the primary lactic acid constituent present; and which compositions feature low irritation, and good antimicrobial efficacy against certain species of bacteria. Treatment processes using the feminine intimate cleansing composition in treatment of the groin area of human females, and vendible products containing the feminine intimate cleansing compositions are also disclosed.Type: GrantFiled: October 18, 2017Date of Patent: February 14, 2023Assignee: RB Health (US) LLCInventors: Sarah Frances De Szalay, Jessica Wilson, Richard Giles
-
Patent number: 11490644Abstract: Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.Type: GrantFiled: August 18, 2020Date of Patent: November 8, 2022Assignee: RB Health (US) LLCInventors: Ed Derohanes, Kenneth Rayl, Michal Siwek, John Williams
-
Patent number: 11278506Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.Type: GrantFiled: October 11, 2016Date of Patent: March 22, 2022Assignee: RB HEALTH (US) LLCInventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
-
Patent number: 10856566Abstract: Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.Type: GrantFiled: February 24, 2016Date of Patent: December 8, 2020Assignee: RB HEALTH (US) LLCInventors: Ed Derohanes, Kenneth Rayl, Michal Siwek, John Williams
-
Publication number: 20200375237Abstract: Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.Type: ApplicationFiled: August 18, 2020Publication date: December 3, 2020Applicant: RB HEALTH (US) LLCInventors: Ed Derohanes, Kenneth Rayl, Michal Siwek, John Williams
-
Publication number: 20190262292Abstract: Disclosed are acidic feminine intimate cleansing compositions having a pH in the range of from 3 to 5, which further necessarily comprises at least: as a primary antimicrobial active constituent, lactic acid, which may optionally be a substituted lactic acid and/or derivative thereof; and which composition further includes an anionic constituent system which boosts the antimicrobial efficacy of the primary lactic acid constituent present; and which compositions feature low irritation, and good antimicrobial efficacy against certain species of bacteria. Treatment processes using the feminine intimate cleansing composition in treatment of the groin area of human females, and vendible products containing the feminine intimate cleansing compositions are also disclosed.Type: ApplicationFiled: October 18, 2017Publication date: August 29, 2019Applicant: RB Health (US) LLCInventors: Sarah Frances DE SZALAY, Jessica WILSON, Richard GILES